感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2018 ACIP建议：百日咳，破伤风和白喉的疫苗预防

2018-04-07 免疫实践咨询委员会 MMWR Recomm Rep. 2018 Apr 27;67(2):1-44.

百日咳破伤风白喉疫苗预防

2018年4月，免疫实践咨询委员会(ACIP)发布了美国百日咳，破伤风和白喉的疫苗预防建议，本文总结了所有关于百日咳，破伤风和白喉预防和控制建议。

中文标题：

2018 ACIP建议：百日咳，破伤风和白喉的疫苗预防

英文标题：

Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

发布机构：

免疫实践咨询委员会

发布日期：

2018-04-07

简要介绍：

2018年4月，免疫实践咨询委员会(ACIP)发布了美国百日咳，破伤风和白喉的疫苗预防建议，本文总结了所有关于百日咳，破伤风和白喉预防和控制建议。 

拓展指南：与百日咳相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ACIP建议：百日咳，破伤风和白喉的疫苗预防)] GetToolGuiderByIdResponse(projectId=1, id=1136b1c001631965, title=2018 ACIP建议：百日咳，破伤风和白喉的疫苗预防, enTitle=Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)., guiderFrom=MMWR Recomm Rep. 2018 Apr 27;67(2):1-44., authorId=null, author=, summary=2018年4月，免疫实践咨询委员会(ACIP)发布了美国百日咳，破伤风和白喉的疫苗预防建议，本文总结了所有关于百日咳，破伤风和白喉预防和控制建议。 , cover=, journalId=null, articlesId=null, associationId=469, associationName=免疫实践咨询委员会, associationIntro=Immunization Action Coalition下分支，服务于疾病控制和预防中心（CDC），制定免疫计划及推荐疫苗使用建议。, copyright=0, guiderPublishedTime=Sat Apr 07 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年4月，免疫实践咨询委员会(ACIP)发布了美国百日咳，破伤风和白喉的疫苗预防建议，本文总结了所有关于百日咳，破伤风和白喉预防和控制建议。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>百日咳</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=f3e911c0008a1953" title="百日咳免疫预防专家共识(2011)" target=_blank>百日咳免疫预防专家共识(2011)</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E7%99%BE%E6%97%A5%E5%92%B3" target=_blank>有关百日咳更多指南</a></ul>, tagList=[TagDto(tagId=13304, tagName=百日咳), TagDto(tagId=7725, tagName=破伤风), TagDto(tagId=22735, tagName=白喉), TagDto(tagId=79592, tagName=疫苗预防)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6680, appHits=232, showAppHits=0, pcHits=4618, showPcHits=2437, likes=103, shares=8, comments=2, approvalStatus=1, publishedTime=Sun Aug 26 23:49:36 CST 2018, publishedTimeString=2018-04-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 26 23:49:36 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 19:15:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ACIP建议：百日咳，破伤风和白喉的疫苗预防)])
2018 ACIP建议：百日咳，破伤风和白喉的疫苗预防
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=341166, encodeId=8de0341166ca, content=哈哈哈，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:25:54 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341121, encodeId=53c43411210e, content=哈哈哈，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:13:47 CST 2018, time=2018-08-27, status=1, ipAttribution=)]
    2018-08-27 huangshang9812

    哈哈哈，学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=341166, encodeId=8de0341166ca, content=哈哈哈，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:25:54 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341121, encodeId=53c43411210e, content=哈哈哈，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Mon Aug 27 14:13:47 CST 2018, time=2018-08-27, status=1, ipAttribution=)]
    2018-08-27 huangshang9812

    哈哈哈，学习了

    0